For example, studies by Moutal et al. investigated the potential of lacosamide (LCM) to interfere with cancer cell proliferation, migration, and invasion by modulating collapsin response mediator protein 2 (CRMP-2), making it a viable target for cancer therapy. The gene discussed is DPYSL2; the disease is cancer.